XML 51 R41.htm IDEA: XBRL DOCUMENT v3.24.2.u1
SEGMENT REPORTING (Tables)
 6 Months Ended
Jun. 30, 2024
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment
The following table presents a summary of the revenues and adjusted EBITDA of our two operating segments for the three and six months ended June 30, 2024 and 2023:
Three Months Ended June 30,Six Months Ended June 30,
(In thousands)2024202320242023
Revenues by segment:
RCM$54,108 $47,760 $107,146 $96,391 
EHR
Recurring revenue
Acute EHR26,666 30,013 54,160 59,353 
Post-acute EHR— 3,729 582 7,636 
Total recurring EHR revenue26,666 33,742 54,742 66,989 
Non-recurring revenue
Acute EHR3,956 2,775 6,008 6,750 
Post-acute EHR— 345 81 725 
Total non-recurring EHR revenue3,956 3,120 6,089 7,475 
Total EHR revenue$30,622 $36,862 $60,831 $74,464 
Total revenues$84,730 $84,622 $167,977 $170,855 
Adjusted EBITDA by segment:
RCM$7,804 $5,682 $14,202 13,580 
EHR4,770 5,545 7,826 12,289 
Total adjusted EBITDA$12,574 $11,227 $22,028 $25,869 
Schedule of Reconciliation of Net Income from Continuing Operations to Adjusted Income (Loss) from Before Interest, Taxes, Depreciation and Amortization
The following table reconciles net income to adjusted EBITDA:
Three Months Ended June 30,Six Months Ended June 30,
(In thousands)2024202320242023
Net income (loss), as reported$(5,049)$(2,837)(7,565)247 
Deferred revenue and other purchase accounting adjustments— — — — 
Depreciation expense400 597 800 1,095 
Amortization of software development costs5,980 1,826 8,722 3,312 
Amortization of acquisition-related intangibles3,126 4,014 6,253 8,029 
Stock-based compensation1,501 (123)2,300 1,124 
Severance and other non-recurring charges4,586 6,819 8,430 7,920 
Interest expense4,151 2,586 8,051 4,988 
Gain on sale of AHT— — (1,250)— 
Provision (benefit) for income taxes(2,121)(1,655)(3,713)(846)
Total adjusted EBITDA$12,574 $11,227 $22,028 $25,869